当前位置:首页 - 行情中心 - 万邦医药(301520) - 财务分析 - 现金流量表

万邦医药

(301520)

  

流通市值:9.08亿  总市值:27.43亿
流通股本:2207.34万   总股本:6666.67万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金40,986,698.6238,950,714.55206,392,917.39136,319,130.94
  客户存款和同业存放款项净增加额00-0
  向中央银行借款净增加额00-0
  向其他金融机构拆入资金净增加额00-0
  收到原保险合同保费取得的现金00-0
  收到再保险业务现金净额00-0
  保户储金及投资款净增加额00-0
  收取利息、手续费及佣金的现金00-0
  拆入资金净增加额00-0
  回购业务资金净增加额00-0
  收到的税费返还003,374,672.253,374,672.25
  收到其他与经营活动有关的现金845,264.3813,768,756.811,195,235.978,555,296.14
  经营活动现金流入的其他项目00-0
  经营活动现金流入小计41,831,962.98252,719,471.35220,962,825.61148,249,099.33
  购买商品、接受劳务支付的现金21,282,096.46174,160,007.49137,163,132.8576,370,804.46
  客户贷款及垫款净增加额00-0
  存放中央银行和同业款项净增加额00-0
  支付原保险合同赔付款项的现金00-0
  支付利息、手续费及佣金的现金00-0
  支付保单红利的现金00-0
  支付给职工以及为职工支付的现金15,909,576.5270,905,105.6454,721,999.0641,626,814.66
  支付的各项税费596,278.332,457,474.545,315,271.124,360,006
  支付其他与经营活动有关的现金8,415,887.1713,119,722.2517,403,026.1213,352,505.06
  经营活动现金流出的其他项目00-0
  经营活动现金流出小计46,203,838.48260,642,309.92214,603,429.15135,710,130.18
  经营活动产生的现金流量净额-4,371,875.5-7,922,838.576,359,396.4612,538,969.15
二、投资活动产生的现金流量:
  收回投资收到的现金351,210,447.121,615,365,243.211,232,768,589.54804,925,497.74
  取得投资收益收到的现金2,989,028.3617,508,539.6212,918,535.666,645,443.3
  处置固定资产、无形资产和其他长期资产收回的现金净额874.3479,538.8300
  投资活动现金流入小计354,200,349.821,632,953,321.661,245,687,125.2811,570,941.04
  购建固定资产、无形资产和其他长期资产支付的现金10,111,235.919,219,763.2427,901,575.6518,034,599
  投资支付的现金432,018,219.181,599,204,967.751,308,204,967.75878,767,842.1
  投资活动现金流出小计442,129,455.081,618,424,730.991,336,106,543.4896,802,441.1
  投资活动产生的现金流量净额-87,929,105.2614,528,590.67-90,419,418.2-85,231,500.06
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金023,207,615.6321,893,285.1321,893,285.13
  支付其他与筹资活动有关的现金012,394,84212,394,84212,394,842
  筹资活动现金流出小计035,602,457.6334,288,127.1334,288,127.13
  筹资活动产生的现金流量净额0-35,602,457.63-34,288,127.13-34,288,127.13
五、现金及现金等价物净增加额-92,300,980.76-28,996,705.53-118,348,148.87-106,980,658.04
  加:期初现金及现金等价物余额150,297,730.04179,294,435.57179,294,435.57179,294,435.57
  期末现金及现金等价物余额57,996,749.28150,297,730.0460,946,286.772,313,777.53
补充资料:
  净利润-36,434,453.57-26,811,405.38
  资产减值准备-7,128,279.55-2,380,253.25
  固定资产和投资性房地产折旧-15,527,624.54-7,778,105.95
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-15,527,624.54-7,778,105.95
  无形资产摊销-1,503,486.41-540,828.76
  长期待摊费用摊销-2,768,740.17-1,935,182.59
  处置固定资产、无形资产和其他长期资产的损失-55,767.7-0
  固定资产报废损失-483,831.51--
  公允价值变动损失--18,983,525.97--11,515,386.15
  财务费用-0--
  投资损失--12,933,909.07--2,638,364.11
  递延所得税--1,553,002.05--2,020,736.99
  其中:递延所得税资产减少--31,730.55--345,337.48
    递延所得税负债增加--1,521,271.5--1,675,399.51
  存货的减少-1,088,911.99-976,231.02
  经营性应收项目的减少--37,811,035.19--6,986,528.08
  经营性应付项目的增加--2,828,111.82--4,722,022.47
  其他-1,195,650.09--
  现金的期末余额-150,297,730.04-72,313,777.53
  减:现金的期初余额-179,294,435.57-179,294,435.57
  现金及现金等价物的净增加额--28,996,705.53--106,980,658.04
公告日期2026-04-232026-04-232025-10-232025-08-26
审计意见(境内)标准无保留意见
TOP↑